Invesco S&P 500 Equal Weight Real Estate ETF (RSPR)
- Previous Close
37.11 - Open
37.28 - Bid 37.64 x 800
- Ask 40.00 x 1400
- Day's Range
37.53 - 37.87 - 52 Week Range
28.00 - 38.80 - Volume
6,772 - Avg. Volume
16,993 - Net Assets 114.06M
- NAV 36.72
- PE Ratio (TTM) --
- Yield 2.52%
- YTD Daily Total Return 13.82%
- Beta (5Y Monthly) 1.15
- Expense Ratio (net) 0.40%
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Real Estate Index (the “parent index”). The parent index is designed to measure the performance of equity securities of larger U.S. companies.
Invesco
Fund Family
Real Estate
Fund Category
114.06M
Net Assets
2015-08-12
Inception Date
Performance Overview: RSPR
View MoreTrailing returns as of 11/7/2024. Category is Real Estate.
Holdings: RSPR
View MoreTop 10 Holdings (34.95% of Total Assets)
Sector Weightings
Related ETF News
View More
Research Reports: RSPR
View MoreIdexx Labs Earnings: Softness in Vet Clinic Visits Weighs on Diagnostic Growth and Shares
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
RatingPrice TargetWhat does Argus have to say about BIO?
BIO-RAD LABORATORIES-A has an Investment Rating of SELL; a target price of $274.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $498.00
IDEXX LABORATORIES INC has an Investment Rating of HOLD; a target price of $498.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $499.00
IDEXX LABORATORIES INC has an Investment Rating of HOLD; a target price of $499.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target